M31.7 Microscopic polyangiitis

Name of the Condition

• Microscopic polyangiitis

Summary

Microscopic polyangiitis is a systemic necrotizing vasculitis that primarily affects small blood vessels, including arterioles, capillaries, and venules. It is characterized by inflammation and necrosis of vessel walls, which can lead to organ damage due to impaired blood flow. The condition is often associated with antineutrophil cytoplasmic antibodies (ANCA), particularly MPO-ANCA, and can involve multiple organs, including the kidneys, lungs, skin, and nerves.

Causes

Microscopic polyangiitis is an autoimmune disorder caused by immune-mediated inflammation of small blood vessels. The exact triggers are not fully understood, but it involves the production of autoantibodies that target neutrophil proteins, leading to vessel wall damage. Genetic predisposition and environmental factors, such as infections or exposures, may contribute to disease onset.

Risk Factors

• Autoimmune conditions (e.g., other vasculitides, rheumatoid arthritis).
• Age (more common in older adults).
• Gender (slight male predominance).
• Exposure to certain medications or environmental triggers (e.g., silica, infections).

Symptoms

• Kidney involvement: Rapidly progressive glomerulonephritis, hematuria, proteinuria, or renal failure.
• Lung involvement: Cough, hemoptysis, or alveolar hemorrhage.
• Skin manifestations: Palpable purpura, ulcers, or necrotic lesions.
• Neurological symptoms: Peripheral neuropathy (mononeuritis multiplex) or sensory deficits.
• General symptoms: Fever, fatigue, weight loss, or arthralgias.

Diagnosis

Diagnosis requires a combination of clinical evaluation, laboratory testing, and histopathological confirmation. Key steps include assessing for systemic vasculitis, measuring ANCA levels (especially MPO-ANCA), and performing a biopsy of affected tissue (e.g., kidney or skin) to demonstrate necrotizing vasculitis. Imaging may be used to evaluate organ involvement, and other causes of vasculitis must be excluded.

Treatment Options

• Induction therapy: High-dose corticosteroids (e.g., prednisone) combined with immunosuppressants (e.g., cyclophosphamide or rituximab) to control acute inflammation.
• Maintenance therapy: Lower-dose immunosuppressants (e.g., azathioprine, methotrexate) to prevent relapse.
• Plasma exchange: For severe renal or pulmonary involvement.
• Supportive care: Management of organ dysfunction (e.g., dialysis for kidney failure) and infection prevention.

Prognosis and Follow-Up

With early diagnosis and treatment, prognosis has improved, but relapses can occur. Long-term follow-up is essential to monitor for organ damage, treatment side effects, and disease recurrence. Regular assessments of renal function, pulmonary status, and ANCA levels are typically performed. Mortality is associated with severe organ involvement, particularly renal or pulmonary disease.

Complications

• Renal failure: Due to glomerulonephritis.
• Pulmonary hemorrhage: Can be life-threatening.
• Peripheral neuropathy: May cause chronic pain or disability.
• Infection: From immunosuppressive therapy.
• Cardiovascular disease: Increased risk due to chronic inflammation.

Lifestyle & Prevention

• Avoid triggers: Minimize exposure to potential environmental or medication-related triggers.
• Infection prevention: Stay up-to-date with vaccinations and practice good hygiene.
• Regular monitoring: Adhere to follow-up appointments to detect relapses or complications early.
• Healthy habits: Maintain a balanced diet, exercise, and manage stress to support overall health.

When to Seek Professional Help

Seek immediate medical attention if you experience:

• Sudden onset of hemoptysis (coughing up blood).
• Severe abdominal or chest pain.
• Rapidly worsening kidney function (e.g., decreased urine output, swelling).
• New or worsening neurological symptoms (e.g., weakness, numbness).
• Unexplained fever, fatigue, or weight loss with systemic symptoms.

Tips for Medical Coders

When coding for microscopic polyangiitis (M31.7), ensure documentation supports the diagnosis, including clinical findings (e.g., vasculitis in small vessels), organ involvement, and ANCA status. Note any associated complications or treatments, as these may impact coding specificity. Verify that the diagnosis aligns with the clinical presentation and exclude other vasculitides or conditions that mimic the disease.